Hydrogen Therapy Shows Promise for Inherited Blindness Treatment

Scientists found that hydrogen gas might help save people's eyesight from a disease called retinitis pigmentosa, which causes blindness by slowly destroying the cells in your eyes—hydrogen works by getting rid of harmful stuff inside cells that makes them die off.

Hydrogen may selectively neutralize harmful reactive oxygen species in retinal tissue while preserving the beneficial oxidation-reduction reactions needed for cell survival, potentially offering a novel approach to slow photoreceptor degeneration in retinitis pigmentosa.

Retinitis pigmentosa is an inherited eye disease where light-sensing cells in the retina gradually die, leading to vision loss. This paper proposes that hydrogen gas might help protect these cells by neutralizing harmful molecules called reactive oxygen species (ROS) that damage them. The authors argue that hydrogen could be a good candidate for treatment because it can eliminate these harmful molecules without disrupting the normal chemical processes cells need to survive.

This is a theoretical proposal, not a completed study with results—no human trials have been conducted yet. While the reasoning about hydrogen's antioxidant properties is scientifically sound, this represents early-stage thinking rather than evidence that hydrogen water would help retinitis pigmentosa patients. Testing in animal models and human clinical trials would be needed before any therapeutic claims could be made.

Retinitis pigmentosa (RP) is a heterogeneous group of inherited retinal dystrophies characterized by progressive photoreceptor apoptosis. Reactive oxygen species (ROS) have been recognized as critical initiators of the photoreceptor apoptosis in RP. Photoreceptor survival in RP mutants will not…

Read the full abstract on PubMed